Skip to main content

Advertisement

Table 1 Postmortem human brains used in the study of sPLA2-IIA expression

From: Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease

Cases Clinical Diagnosis Gender Age (years) PMI (hours) Type of Study Brain Region
1 ND M 78 2.7 IHC ITG
2 ND M 81 2.7 IHC I TG
3 ND M 69 2.2 IHC HPC, ITG
4 ND M 84 2.5 IHC HPC, ITG
5 ND M 78 1.7 IHC HPC, ITG
6 ND M 94 3.0 RNA HPC, CB
7 ND M 85 3.2 RNA HPC, CB
8 ND F 85 2.5 RNA HPC, CB
9 ND F 86 2.0 RNA HPC, CB
10 ND F 88 3.0 RNA HPC, CB
11 ND F 94 2.5 RNA HPC, CB
12 ND F 86 2.5 RNA HPC, CB,
13 ND F 83 2.5 RNA HPC, CB
14 ND F 94 2.3 RNA HPC, CB,
15 ND F 78 2.8 IHC ITG
      RNA HPC, CB
16 ND F 88 3.5 RNA HPC, CB
17 AD M 86 3.0 IHC ITG
18 AD M 87 3.0 IHC HPC
      RNA HPC, CB
19 AD M 79 2.0 IHC HPC
      RNA HPC, CB
20 AD M 94 3.8 IHC ITG
21 AD M 92 2.0 IHC ITG
22 AD F 89 3.0 IHC HPC
      RNA HPC, CB
23 AD F 80 2.3 IHC HPC, ITG
24 AD F 85 1.7 RNA HPC, CB
25 AD F 95 3.2 RNA HPC, CB
26 AD F 91 3.0 RNA HPC, CB
27 AD F 89 2.3 RNA HPC, CB
28 AD F 97 1.5 IHC ITG
29 AD F 64 3.2 IHC ITG
30 AD F 77 2.8 IHC ITG
31 AD F 85 2.3 IHC HPC
32 AD F 90 3.0 RNA HPC, CB
  1. Abbreviations: ND: Non Demented Control, AD: Alzheimer's Disease, M: Male; F: Female; PMI: Post Mortem Interval; IHC: Immunohistochemistry; HPC: Hippocampus; ITG: Inferior Temporal Gyrus, CB: Cerebellum.